P2 is to assess safety and efficacy, compared to a placebo. Genoa's P2 trial was started a year ahead but at a 55% reduction of viral shedding, it can only ever aspire to be therapeutic vaccine, not curative as Frazer's approach. So hopefully we will see a significantly lower % of viral shedding than Genoa's results
Flood of Foreign Cash Headed Into Small Cap Stocks, page-12
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.88 |
Change
-0.120(1.20%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $50.29K | 5.119K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 56 | $9.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 530 | 3 |
View Market Depth
| Last trade - 13.59pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |